Home » Topics » BioWorld Science

BioWorld Science
RSS

New psilocin prodrugs discovered at Compass Pathfinder

March 15, 2022

Council of Scientific and Industrial Research patents nigericin derivatives

March 15, 2022

1st Bio Therapeutics identifies new ABL/LRRK2/LRRK2 mutant/RIPK2 inhibitors

March 15, 2022

2-Benzyllawsone shown to protect mice against polymicrobial sepsis

March 15, 2022

Bright Minds' BMB-101 for Dravet syndrome completes 28-day repeat toxicity studies

March 14, 2022

Del-1 potentiates BCI efficacy by blockade of tumor-infiltrating neutrophils

March 14, 2022

Discovery of novel MDM2 inhibitor with antitumor activity in p53 wild-type cancer models

March 14, 2022

FDA grants orphan drug designation to HT-KIT for mastocytosis

March 14, 2022

Targeting PTP1B enhances T cell-mediated antitumor immunity

March 14, 2022

Study reveals dopamine as a sleep disorders target

March 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...